Iterum Therapeutics plc (ITRM)
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 24.07M |
| Enterprise Value | 33.60M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.03 |
| Enterprise Value/Revenue | 105.22 |
| Enterprise Value/EBITDA | 0.55 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.26 |
| 52-Week Change 3 | 39.66% |
| S&P500 52-Week Change 3 | 26.76% |
| 52 Week High 3 | 2.5000 |
| 52 Week Low 3 | 0.6220 |
| 50-Day Moving Average 3 | 1.2151 |
| 200-Day Moving Average 3 | 1.4771 |
Share Statistics
| Avg Vol (3 month) 3 | 308.4k |
| Avg Vol (10 day) 3 | 510.94k |
| Shares Outstanding 5 | 22.71M |
| Implied Shares Outstanding 6 | 22.71M |
| Float 8 | 21.96M |
| % Held by Insiders 1 | 1.81% |
| % Held by Institutions 1 | 3.05% |
| Shares Short (Aug 30, 2024) 4 | 222.83k |
| Short Ratio (Aug 30, 2024) 4 | 0.74 |
| Short % of Float (Aug 30, 2024) 4 | 1.01% |
| Short % of Shares Outstanding (Aug 30, 2024) 4 | 0.98% |
| Shares Short (prior month Jul 31, 2024) 4 | 2.27M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Aug 18, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -73.35% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -37.36M |
| Net Income Avi to Common (ttm) | -28.34M |
| Diluted EPS (ttm) | -1.8300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.72M |
| Total Cash Per Share (mrq) | 0.52 |
| Total Debt (mrq) | 21.62M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.82 |
| Book Value Per Share (mrq) | -0.66 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -41.95M |
| Levered Free Cash Flow (ttm) | -28.46M |
© 2024 Yahoo. All rights reserved.